Stock Analiz

HeartSciences Inc. HSCS

Industrial Specialties · IPO 2022 · data as of November 13, 2026

$2.12Market cap $10M
Open the interactive analysis →

HeartSciences Inc. (HSCS) is a healthcare company listed in the US with a market value of about $10M. In the twelve months to July 31, 2026 it had revenue of $4519 and net income of -$10M, a net margin of -227024.2%.

Its overall Stock Analiz score is 0.2 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -835%.

About HeartSciences

HeartSciences is listed in the US and classified in industrial specialties, IPO year 2022. Revenue went from $14373 in 2022 to $4319 in 2026, a decline of about 26.0% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 3202% over three years (dilution for shareholders). It spends 65733% of revenue on research and development.

Score: 0.2 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health0/5
Shareholder returns0/5

Checks passed

  • Strong R&D investment or growth above 20%

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S2,278.0
P/B—
EV/EBITDA—
PEG—
Dividend yield—
FCF yield-72.2%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-0.7%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-121100.0%
ROIC (5-yr avg.)-834.5%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 5 years

Fiscal yearTTM20262025202420232022
Revenue$4519$4319$4350$18600$5150$14373
Net income-$10M-$9M-$9M-$7M-$6M-$5M
Free cash flow—-$7M-$7M-$6M-$6M-$4M
EPS (diluted)$-2.76$-3.48$-9.34$-18.74$-80.00$-145.00
Net margin-227024.2%-211700.0%-201500.0%-35511.9%-123400.0%-33592.6%
ROIC—-159.7%-206.8%-59.6%-268.8%-3477.7%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does HeartSciences pay a dividend?

Not currently.

Is HeartSciences a good stock to buy?

We do not give buy or sell advice. HeartSciences scores 0.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.